-

Huntington Hospital – Notice of Unauthorized Access to Personal Information

HUNTINGTON, N.Y.--(BUSINESS WIRE)--Huntington Hospital has sent notices to approximately 13,000 patients about an incident involving the unauthorized access of personal information. The hospital learned that a night shift employee improperly accessed electronic medical patient records in violation of its policies. After a thorough investigation, on February 25, 2019, the hospital determined that the employee improperly accessed patient information without role-based authorization between October 2018 and February 2019. The employee was immediately suspended, and he was subsequently terminated. In addition, Huntington Hospital notified law enforcement of the incident. The hospital cooperated with the law enforcement investigation, which included following instructions to delay notifying any patients who were potentially impacted by this incident through November 2021. The law enforcement investigation resulted in the former employee being charged with a criminal HIPAA violation.

There is no evidence that the former employee accessed Social Security numbers, insurance information, credit card numbers or other payment-related information. The patient information accessed by the former employee may have included demographic-type information such as name, date of birth, telephone number, address, internal account number and medical record number; and clinical information such as diagnoses, medications, laboratory results, course of treatment, the names of health care providers, and/or other treatment-related information.

Huntington Hospital has a robust compliance program that includes ongoing training of its employees, implementation of security tools to monitor access to medical record applications, and audits of medical record access. The hospital has taken additional steps to prevent this type of incident from occurring in the future, including bolstering access controls and targeted re-training of staff on the importance of protecting patient confidentiality.

As an added precaution, Huntington Hospital is offering all impacted patients complimentary identity theft protection services through Experian IdentityWorksSM for one (1) year, unless a longer time period was required by applicable state law.

This notice is being provided in accordance with the media notice requirements of the Health Insurance Portability and Accountability Act, as amended by Health Information Technology for Economic and Clinical Health Act. Huntington Hospital has notified impacted patients and will notify relevant regulatory bodies, including the U.S. Department of Health and Human Services.

Contacts

Barbara Osborn
516-321-6702
bosborn@northwell.edu

Huntington Hospital


Release Versions

Contacts

Barbara Osborn
516-321-6702
bosborn@northwell.edu

More News From Huntington Hospital

Feinstein Institutes Technology That Restores Movement and Sensation After Paralysis Featured in Nature Medicine

MANHASSET, N.Y.--(BUSINESS WIRE)--Nature Medicine today featured on its cover the findings from The Feinstein Institutes for Medical Research, demonstrating that its “double neural bypass” technology can restore immediate function and promote lasting neurological recovery in complete spinal cord injury. The study reveals how the novel hybrid brain computer interface (BCI) system combines cutting-edge BCI technology with artificial intelligence (AI) and high-precision electrical stimulation of t...

Feinstein Institutes Scientists Discover How Bioelectronic Medicine Activates Blood Clotting

MANHASSET, N.Y.--(BUSINESS WIRE)--For centuries, stopping severe bleeding has relied on physical pressure or surgery. A pioneering study from Northwell Health’s Feinstein Institutes for Medical Research now demonstrates that a small, wearable device placed on the ear can activate the vagus nerve and accelerate clot formation, offering new hope against life-threatening hemorrhage.This first-in-human mechanistic study, recently published in the journal Bioelectronic Medicine – an open-access journ...

Renowned Physician-Scientist Brian S. Kim Joins Northwell as First Chief Biotechnology Officer

MANHASSET, N.Y.--(BUSINESS WIRE)--Building on its legacy as the global pioneer in bioelectronic medicine, The Feinstein Institutes for Medical Research, the research home of Northwell Health, today announced the appointment of Brian S. Kim, MD, MTR, as vice president and chief biotechnology officer at Northwell and head of intellectual asset management at the Feinstein Institutes. Dr. Kim will also serve as the inaugural Robin and Jack Ross Chair in Bioelectronic Medicine and Neuroimmunology and...
Back to Newsroom